144 related articles for article (PubMed ID: 29781558)
21. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease.
Verbeke F; Siwy J; Van Biesen W; Mischak H; Pletinck A; Schepers E; Neirynck N; Magalhães P; Pejchinovski M; Pontillo C; Lichtinghagen R; Brand K; Vlahou A; De Bacquer D; Glorieux G
Nephrol Dial Transplant; 2021 Apr; 36(5):811-818. PubMed ID: 31837226
[TBL] [Abstract][Full Text] [Related]
22. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
23. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
24. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
25. Prediction of kidney-related outcomes in patients with type 2 diabetes.
Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J;
Am J Kidney Dis; 2012 Nov; 60(5):770-8. PubMed ID: 22694950
[TBL] [Abstract][Full Text] [Related]
26. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
[TBL] [Abstract][Full Text] [Related]
27. Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction.
Ahn HS; Kim JH; Jeong H; Yu J; Yeom J; Song SH; Kim SS; Kim IJ; Kim K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545899
[TBL] [Abstract][Full Text] [Related]
28. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
Critselis E; Lambers Heerspink H
Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724
[TBL] [Abstract][Full Text] [Related]
29. Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.
Tonneijck L; Muskiet MHA; Smits MM; Hoekstra T; Kramer MHH; Danser AHJ; Diamant M; Joles JA; van Raalte DH
Diabetes Obes Metab; 2017 Dec; 19(12):1669-1680. PubMed ID: 28449402
[TBL] [Abstract][Full Text] [Related]
30. Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study.
Davis TME; Drinkwater J; Davis WA
J Clin Endocrinol Metab; 2017 Aug; 102(8):2985-2993. PubMed ID: 28591820
[TBL] [Abstract][Full Text] [Related]
31. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
[TBL] [Abstract][Full Text] [Related]
32. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes.
Morita M; Uchigata Y; Hanai K; Ogawa Y; Iwamoto Y
Am J Kidney Dis; 2011 Dec; 58(6):915-20. PubMed ID: 21763044
[TBL] [Abstract][Full Text] [Related]
33. Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial.
Ando K; Ohtsu H; Uchida S; Kaname S; Arakawa Y; Fujita T;
Lancet Diabetes Endocrinol; 2014 Dec; 2(12):944-53. PubMed ID: 25466242
[TBL] [Abstract][Full Text] [Related]
34. Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
Rambabova-Bushljetik I; Metzger J; Siwy J; Dohcev S; Bushljetikj O; Filipce V; Trajceska L; Mischak H; Spasovski G
Nephrol Dial Transplant; 2022 Sep; 37(10):2014-2021. PubMed ID: 34634117
[TBL] [Abstract][Full Text] [Related]
35. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
36. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
Joergensen C; Tarnow L; Goetze JP; Rossing P
Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
[TBL] [Abstract][Full Text] [Related]
38. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m
Nitta K; Nagai T; Mizunuma Y; Kitada M; Nakagawa A; Sakurai M; Toyoda M; Haneda M; Kanasaki K; Koya D
Clin Exp Nephrol; 2019 Aug; 23(8):1004-1012. PubMed ID: 30949886
[TBL] [Abstract][Full Text] [Related]
39. Urinary proteomics for early diagnosis in diabetic nephropathy.
Zürbig P; Jerums G; Hovind P; Macisaac RJ; Mischak H; Nielsen SE; Panagiotopoulos S; Persson F; Rossing P
Diabetes; 2012 Dec; 61(12):3304-13. PubMed ID: 22872235
[TBL] [Abstract][Full Text] [Related]
40. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]